1620 Investment Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.5K Sell
174
-34
-16% -$6K 0.01% 401
2026
Q1
$37.3K Hold
208
0.03% 334
2025
Q4
$29.4K Hold
208
0.02% 354
2025
Q3
$16.9K Sell
208
-6
-3% -$463 0.01% 404
2025
Q2
$13.4K Hold
214
0.01% 428
2025
Q1
$15.4K Sell
214
-4
-2% -$326 0.01% 405
2024
Q4
$18.8K Buy
218
+4
+2% +$398 0.01% 395
2024
Q3
$20.3K Buy
214
+11
+5% +$977 0.01% 394
2024
Q2
$19.4K Buy
+203
New +$24.1K 0.01% 393

Other funds holding ALB

1620 Investment Advisors's ALB Position: Q2 2026 in Review

1620 Investment Advisors reduced its Albemarle (ALB) stake by 16% in Q2 2026, selling an estimated $6K and leaving 174 shares worth $23.5K. The position accounts for 0.01% of the portfolio, ranked #401.

1620 Investment Advisors first reported a position in ALB in Q2 2024 and has held it in 9 quarters since. The position peaked at $37.3K in Q1 2026. 937 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • 1620 Investment Advisors held 174 shares of Albemarle worth $23.5K as of Q2 2026.
  • 1620 Investment Advisors sold 34 Albemarle shares in Q2 2026, an estimated $6K.
  • Albemarle made up 0.01% of 1620 Investment Advisors's portfolio in Q2 2026, its #401 holding.
  • 1620 Investment Advisors first reported a position in Albemarle in Q2 2024 and has held it in 9 quarters since.
  • 1620 Investment Advisors's Albemarle position peaked at $37.3K in Q1 2026.
  • 937 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on 1620 Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.